Molecular Study and Precision Medicine for Colorectal Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

July 1, 2026

Study Completion Date

July 1, 2026

Conditions
Advanced Colorectal CarcinomaRecurrent Colorectal Carcinoma
Interventions
OTHER

Molecular Profiling & drug testing in tumor organoids and PDXs

Molecular profiling of native tumor will be performed and analyzed by using a self-designed panel. Tumor organoids will be cultured from fresh tumor tissues and patient-derived xenografts model will be established using the tumor organoids. Drugs will be tested in the two models. And the recommendation will be communicated to the clinicians.

Trial Locations (1)

Unknown

Wuhan Union Hospital, China, Wuhan

All Listed Sponsors
lead

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER